Purchase Order 75D30120P09974
Award Date 9/30/20
Potential Completion Date 9/29/22
Potential Value $249K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $157,351.00 definitive cost-no-fee contract to The Ohio State University to conduct research on Salmonella in the dairy production chain. This research contract has a completion date of February 29, 2020. The Ohio State University is a public research university that has extensive experience conducting various types of research and providing services to federal agencies under both contracts and...
- This is a definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Ohio State University for the "OHIO STATE ORGANISMS & GENES STUDY." The contract, which does not have a set-aside designation, was awarded on September 30, 2018 with a potential value of $385,853.00 and a completion date of December 31, 2019. As a public research university, The Ohio State University has a history of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $155,333.00 definitive contract to The Ohio State University to conduct a study on antibiotic stewardship under a Broad Agency Announcement (BAA). The contract is a cost-no-fee arrangement with a completion date of February 29, 2020. The Ohio State University, a public research university, has experience conducting a variety of federally funded research and support services for agencies such as the...
- This is a $85,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University to provide support services to improve the detection of emerging meningococcal urethritis. The award does not have a set-aside designation. The Ohio State University is a public research university that has previously provided various goods and services to federal agencies, including coordination and support services for clinical trials, infrastructure...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies,...
- This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Ohio State University in the amount of $630,103.00. The contract has a firm fixed price pricing type and a completion date of April 30, 2023. It was awarded on August 1, 2020 and does not have a set-aside designation. The contract is for FY20 BAA TOPIC 5.5 and the place of performance is Chamblee, Georgia. The Ohio State University is a public research university...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University (OSU) for the testing of parenterally administered live attenuated rotavirus, with a completion date of September 5, 2025 and a ceiling value of $248,005.00. The contract does not have a set-aside designation. OSU is a public research university that has a history of providing various goods and services to federal agencies, including coordination and support...
- This is a $473,312 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Ohio State University to prevent the dissemination of carbapenem-resistant Enterobacteriaceae (CRE). The contract has a period of performance from September 15, 2016 to September 29, 2017 and is a cost-no-fee contract. The Ohio State University has previously received other federal contract awards and grants, including work for the National Institutes of Health, NASA, the Drug...
- This is a federal contract award from the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to The Ohio State University (OSU) for a study on small specialty farming produce. The contract is a firm-fixed-price purchase order with a potential value of $110,600.00. The contract was awarded on September 11, 2017 and the period of performance is through September 14, 2018. The contract does not have a set-aside designation. As a public research university, OSU has...
- This federal contract award in the amount of $97,584.97 was issued by the Food and Drug Administration (FDA) to The Ohio State University. The award is part of the OARSA CONSORTIUM and has a period of performance ending on September 30, 2017. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials...